Published in Crit Care Med on December 01, 2010
Factors influencing physical functional status in intensive care unit survivors two years after discharge. BMC Anesthesiol (2013) 1.48
Health-related quality of life and physical recovery after a critical illness: a multi-centre randomised controlled trial of a home-based physical rehabilitation program. Crit Care (2011) 1.45
Patterns of depressive symptoms in caregivers of mechanically ventilated critically ill adults from intensive care unit admission to 2 months postintensive care unit discharge: a pilot study. Crit Care Med (2012) 1.45
Variation exists in rates of admission to intensive care units for heart failure patients across hospitals in the United States. Circulation (2013) 1.37
Early intra-intensive care unit psychological intervention promotes recovery from post traumatic stress disorders, anxiety and depression symptoms in critically ill patients. Crit Care (2011) 1.18
The reality of patients requiring prolonged mechanical ventilation: a multicenter study. Rev Bras Ter Intensiva (2015) 0.88
Exercise rehabilitation following hospital discharge in survivors of critical illness: an integrative review. Crit Care (2012) 0.88
Quality of life before admission to the intensive care unit. Rev Bras Ter Intensiva (2012) 0.87
Functional and psychological features immediately after discharge from an intensive care unit: prospective cohort study. Rev Bras Ter Intensiva (2013) 0.87
Long-term quality of life in critically ill patients with acute kidney injury treated with renal replacement therapy: a matched cohort study. Crit Care (2015) 0.84
Natural Language Processing to Assess Documentation of Features of Critical Illness in Discharge Documents of Acute Respiratory Distress Syndrome Survivors. Ann Am Thorac Soc (2016) 0.80
Long-term survival and quality of life after intensive care for patients 80 years of age or older. Ann Intensive Care (2015) 0.80
AKI patients have worse long-term outcomes, especially in the immediate post-ICU period. Crit Care (2012) 0.79
Long term health-related quality of life in survivors of sepsis in South West Wales: an epidemiological study. PLoS One (2014) 0.78
A prospective longitudinal multicentre study of health related quality of life in ICU survivors with COPD. Crit Care (2013) 0.78
Long-term treated intensive care patients outcomes: the one-year mortality rate, quality of life, health care use and long-term complications as reported by general practitioners. BMC Anesthesiol (2015) 0.77
Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome. Thorax (2016) 0.76
Moving beyond the assessment of mortality and severity of diseases in critical patients: we are just getting started... Rev Bras Ter Intensiva (2012) 0.75
Outcomes and Health-related Quality of Life following Intensive Care Unit Stay in Barbados. West Indian Med J (2014) 0.75
Year in review 2012: Critical Care--management. Crit Care (2013) 0.75
Impairments, activity limitations and participation restrictions experienced in the first year following a critical illness: protocol for a systematic review. BMJ Open (2017) 0.75
From self-awareness to self-actualization: empowering sepsis survivors to a meaningful and enduring recovery. J Thorac Dis (2016) 0.75
Public versus Private Healthcare Systems following Discharge from the ICU: A Propensity Score-Matched Comparison of Outcomes. Biomed Res Int (2016) 0.75
Exercise rehabilitation following intensive care unit discharge for recovery from critical illness: executive summary of a Cochrane Collaboration systematic review. J Cachexia Sarcopenia Muscle (2016) 0.75
Early rehabilitation for the prevention of postintensive care syndrome in critically ill patients: a study protocol for a systematic review and meta-analysis. BMJ Open (2017) 0.75
PReventing early unplanned hOspital readmission aFter critical ILlnEss (PROFILE): protocol and analysis framework for a mixed methods study. BMJ Open (2016) 0.75
The role of memories on health-related quality of life after intensive care unit care: an unforgettable controversy? Patient Relat Outcome Meas (2016) 0.75
Long-term outcome and health-related quality of life in difficult-to-wean patients with and without ventilator dependency at ICU discharge: a retrospective cohort study. BMC Pulm Med (2016) 0.75
The association of time and medications with changes in bone mineral density in the 2 years after critical illness. Crit Care (2017) 0.75
Changes in health-related quality of life (HRQoL) after discharge from intensive care unit: a protocol for a systematic review. BMJ Open (2015) 0.75
Health-related quality of life scores after intensive care are almost equal to those of the normal population: a multicenter observational study. Crit Care (2013) 0.75
Factors influencing decline of physical functional status among icu survivors: a prospective cohort study. Intensive Care Med Exp (2015) 0.75
Project Post Intensive Care eXercise (PIX): A qualitative exploration of intensive care unit survivors' perceptions of quality of life post-discharge and experience of exercise rehabilitation. J Intensive Care Soc (2014) 0.75
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. Value Health (2007) 3.93
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health (2011) 3.88
Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol (2003) 3.16
Perceptions of appropriateness of care among European and Israeli intensive care unit nurses and physicians. JAMA (2011) 3.11
Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med (2011) 3.03
Systematic review: Effects, design choices, and context of pay-for-performance in health care. BMC Health Serv Res (2010) 2.70
Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med (2008) 2.31
Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis (2005) 2.26
Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med (2003) 2.26
Education in pharmacoeconomics: an international multidisciplinary view. Pharmacoeconomics (2004) 2.25
A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan. Intern Med (2007) 2.17
Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med (2005) 2.16
Discounting health effects in pharmacoeconomic evaluations: current controversies. Pharmacoeconomics (2005) 1.71
Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med (2006) 1.71
A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients. Diabetes Care (2002) 1.50
Centers for Disease Control and Prevention guidelines for preventing central venous catheter-related infection: results of a knowledge test among 3405 European intensive care nurses. Crit Care Med (2009) 1.48
Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial. BMC Public Health (2013) 1.44
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC Cancer (2013) 1.43
Reduction of catheter related bloodstream infections in intensive care: one for all, all for one? Nurs Crit Care (2009) 1.41
Thinking ahead--the rising tide of AIDS orphans. S Afr Med J (2005) 1.41
Economic evaluations in healthcare: comments on a recent article. Reprod Biomed Online (2005) 1.40
Critical care nursing: towards 2015. Nurs Crit Care (2009) 1.39
Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure. Chest (2004) 1.31
Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit Care (2008) 1.28
Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant (2005) 1.18
Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung (2009) 1.14
Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection. Int J Antimicrob Agents (2008) 1.11
Cost effectiveness of treatments for wet age-related macular degeneration. Pharmacoeconomics (2011) 1.09
What reimbursement for coronary revascularization with drug-eluting stents? Eur J Health Econ (2004) 1.09
The ties that bind: an integrative framework of physician-hospital alignment. BMC Health Serv Res (2011) 1.08
Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review. Int J Behav Nutr Phys Act (2011) 1.08
Determinants of procedural pain intensity in the intensive care unit. The Europain® study. Am J Respir Crit Care Med (2014) 1.05
Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy. Mov Disord (2008) 1.03
The impact of disease stage on direct medical costs of HIV management: a review of the international literature. Pharmacoeconomics (2010) 1.02
Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey. Int J Cardiol (2012) 1.02
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial. Br J Ophthalmol (2012) 1.01
The impact of the initial ventilatory strategy on survival in hematological patients with acute hypoxemic respiratory failure. J Crit Care (2009) 1.00
Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccination. Vaccine (2008) 0.98
Acute effects of upright position on gas exchange in patients with acute respiratory distress syndrome. J Intensive Care Med (2005) 0.98
Psychological well-being and socio-economic hardship among AIDS orphans and other vulnerable children in Guinea. AIDS Care (2009) 0.97
Adherence to and efficacy and safety of an insulin protocol in the critically ill: a prospective observational study. Am J Crit Care (2007) 0.96
Differential pricing of new pharmaceuticals in lower income European countries. Expert Rev Pharmacoecon Outcomes Res (2013) 0.96
Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis. Expert Rev Pharmacoecon Outcomes Res (2013) 0.94
Reflections on market access for personalized medicine: recommendations for Europe. Value Health (2013) 0.93
Health technology assessments in personalized medicine: illustrations for cost-effectiveness analysis. Expert Rev Pharmacoecon Outcomes Res (2011) 0.92
Epidemiology of infection in critically ill patients with acute renal failure. Crit Care Med (2009) 0.91
Facilitating clinician adherence to guidelines in the intensive care unit. Crit Care Med (2008) 0.91
Pay-for-performance step-by-step: introduction to the MIMIQ model. Health Policy (2010) 0.91
A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease. Pharmacoeconomics (2006) 0.90
EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristics. Am Heart J (2012) 0.89
The equity dimension in evaluations of the quality and outcomes framework: a systematic review. BMC Health Serv Res (2011) 0.88
Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome. Intensive Care Med (2005) 0.88
Cost-effectiveness analysis of bicalutamide (Casodex) for adjuvant treatment of early prostate cancer. Value Health (2004) 0.87
The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism. Eur J Nucl Med Mol Imaging (2008) 0.87
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis. Arch Orthop Trauma Surg (2004) 0.87
Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study. BMC Infect Dis (2007) 0.86
A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction. Pharmacoeconomics (2006) 0.86
Economic impact of enoxaparin after acute ischemic stroke based on PREVAIL. Clin Appl Thromb Hemost (2010) 0.86
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases. Pharmacoeconomics (2004) 0.85
Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results. Clin Drug Investig (2008) 0.85
A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels. Acta Gastroenterol Belg (2007) 0.85
A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium. Clin Ther (2005) 0.85
Causes and consequences of disproportionate care in intensive care medicine. Curr Opin Crit Care (2013) 0.84
Cost effectiveness of darunavir/ritonavir 600/100 mg bid in protease inhibitor-experienced, HIV-1-infected adults in Belgium, Italy, Sweden and the UK. Pharmacoeconomics (2010) 0.84
Economic burden of pertussis and the impact of immunization. Pediatr Infect Dis J (2005) 0.84
Expected net benefit of clinical pharmacy in intensive care medicine: a randomized interventional comparative trial with matched before-and-after groups. J Eval Clin Pract (2014) 0.83
The impact of economic and noneconomic exchange on physicians' organizational attitudes: The moderating effects of the Chief Medical Officer. Health Care Manage Rev (2015) 0.83
Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project. Eur Heart J (2012) 0.83
Hospital-physician relations: the relative importance of economic, relational and professional attributes to organizational attractiveness. BMC Health Serv Res (2014) 0.82
Economic evaluation of different treatment modalities in acute kidney injury. Nephrol Dial Transplant (2012) 0.82
Sexual experience and HIV-related knowledge among Belgian university students: a questionnaire study. BMC Res Notes (2014) 0.81
Projected reduction in healthcare costs in Belgium after optimization of iodine intake: impact on costs related to thyroid nodular disease. Thyroid (2010) 0.81
A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany. Expert Rev Pharmacoecon Outcomes Res (2012) 0.81
An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings. Nephrol Dial Transplant (2003) 0.81
Non-invasive ventilation in patients with hematological malignancies: the saga continues, but where is the finale? Intensive Care Med (2010) 0.81
A cost-effectiveness study of the community-based intervention '10 000 Steps Ghent'. Public Health Nutr (2011) 0.81
Cost-effectiveness of dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation in Belgium. J Med Econ (2013) 0.81
Cost effectiveness of a pharmacist-led information technology intervention for reducing rates of clinically important errors in medicines management in general practices (PINCER). Pharmacoeconomics (2014) 0.81
Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies. Intensive Care Med (2010) 0.81
Nurses' knowledge of evidence-based guidelines for the prevention of surgical site infection. Worldviews Evid Based Nurs (2009) 0.81
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria. Kidney Int Suppl (2005) 0.81
End-of-life care of the geriatric patient and nurses' moral distress. J Am Med Dir Assoc (2011) 0.81
Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trial. J Hosp Med (2011) 0.81
European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment. Cancer Treat Rev (2006) 0.80
A critical literature review of health economic evaluations in pertussis booster vaccination. Expert Rev Pharmacoecon Outcomes Res (2012) 0.80
Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines. Trop Med Int Health (2010) 0.80
The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy. Clin Ther (2003) 0.80